JOIN THE FIGHT

Help us better understand the experiences of individuals living with epilepsy by participating in this anonymous survey conducted by Harris Poll, a leading international research firm, about your experiences with seizures. The survey can only be taken once and will take about 20 minutes. Thank you in advance for your participation!

View our latest videos.

EFGC 2014 Walk PSA

walk 2014 psa

 

 

 Story Days: Charles (Epilepsy Awareness Month) 

cover photo

 

 

 Join the Fight

YouTube Video

LATEST EFGC NEWS

333 Patient Groups Join Together to Ask HHS Secretary Burwell to Reduce Barriers to Care in Qualified Health Plans

Three-hundred-and-thirty-three patient groups from around the country have signed onto a letter to Secretary of Health and Human Services (HHS) Sylvia Mathews Burwell calling for immediate measures to reduce barriers to care for patients who have purchased policies through the Health Insurance Marketplace (the “exchanges”). The letter comes as some patients with chronic conditions have faced difficulty accessing crucial medications and other health services they need in some Qualified Health Plans, and as HHS is reviewing plans for 2015.

Posted in Home-News | Comments closed

Governor Pat Quinn Signs the Amendment on the Medical Marijuana Law

On July 20, 2014 SB 2636, the medical marijuana law adding epilepsy as a debilitating medical condition was signed by IL Governor Pat Quinn. This amendment includes epilepsy as one of the conditions for which medical marijuana may be prescribed, and that pediatric intractable cases of epilepsy may be permitted to use cannabis oil in the treatment of childhood seizures. The amendment was passed by the Illinois Senate with a vote of 49-5 on April 2, 2014 and the Illinois House of Representatives with a vote of 98-18 on May 21, 2014.

Posted in Home-News, News | Comments closed

U.S. Department of Defense Allocates $7.5 million to Epilepsy Research

On July 17, 2014, the U.S. Department of Defense announced that it will allocate $7.5 million to epilepsy research due to the alarming increase of people diagnosed with epilepsy because of Traumatic Brain Injuries sustained in the wars in Iraq and Afghanistan since 2006. This initiative was led by Illinois Senator Dick Durbin and Susan Axelrod of Citizens United for Research in Epilepsy (CURE).

Posted in Home-News, Press Room | Comments closed

2014 Scholarship Winners

The 2014 recipients of the Jim Davies Scholarship were announced at the Epilepsy Foundation of Greater Chicago’s June Board of Directors Meeting. This scholarship is awarded annually in the amount of $1,000 to individuals with epilepsy who will be incoming freshmen to a college or vocational/technical school and will be a full-time student for the 2014/2015 academic school year. Congratulations to the following students for their strong commitment to their education and perseverance in overcoming the obstacles epilepsy may present:

Posted in Home-News, Press Room | Comments closed

Neurosurgeons implant new type of electrical stimulator to control seizures

On June 18, neurosurgeons at the University of Alabama at Birmingham implanted a new type of electrical stimulator to control seizures in patients with difficult-to-control epilepsy. It marked the first time in the Southeast the RNS system by NeuroPace had been implanted since the device gained FDA approval in November 2013. The first patient was a 24-year-old woman from central Alabama.

Posted in Home-News | Comments closed

Early treatment with AED reduces duration of febrile seizures

New research shows that children with febrile status epilepticus (FSE) who receive earlier treatment with antiepileptic drugs (AEDs) experience a reduction in the duration of the seizure. The study published in Epilepsia, a journal of the International League Against Epilepsy (ILAE), suggests that a standard Emergency Medical Services (EMS) treatment protocol for FSE is needed in the U.S.

Posted in Home-News, Press Room | Comments closed

FDA okays medical device to treat epilepsy

The U.S. Food and Drug Administration has approved a device to help reduce the frequency of seizures in epilepsy patients who have not responded well to medications in the past.

Posted in Home-News | Comments closed